efficacy

• 

Real-world outcomes of nivolumab and cabozantinib for metastatic kidney cancer

By Sharon Kell|2019-05-20T08:59:34+00:0020 May 2019|Drug treatments|

A retrospective study using data from the International Metastatic Renal [...]

Read More

Comments Off on Real-world outcomes of nivolumab and cabozantinib for metastatic kidney cancer

• 

Immunotherapy for genitourinary cancer in the elderly

By Sharon Kell|2019-04-29T08:22:39+00:0029 Apr 2019|Drug treatments|

In the following interview, Dr Bradley McGregor, a medical oncologist [...]

Read More

Comments Off on Immunotherapy for genitourinary cancer in the elderly

• 

Anlotinib versus sunitinib as first-line treatment for metastatic kidney cancer

By Sharon Kell|2019-03-27T09:47:33+00:0027 Mar 2019|Drug treatments|

The results of a recent phase 2 study to evaluate [...]

Read More

Comments Off on Anlotinib versus sunitinib as first-line treatment for metastatic kidney cancer

• 

Nivolumab is safe and effective for older kidney cancer patients

By Sharon Kell|2018-07-20T08:56:27+00:0020 Jul 2018|Drug treatments|

Findings from an expanded access programme giving 389 metastatic renal [...]

Read More

Comments Off on Nivolumab is safe and effective for older kidney cancer patients

• 

Antibiotics may impair the efficacy of immunotherapy in kidney cancer

By Sharon Kell|2017-02-22T15:41:09+00:0022 Feb 2017|Drug treatments|

A study presented at the American Society of Clinical Oncology [...]

Read More

Comments Off on Antibiotics may impair the efficacy of immunotherapy in kidney cancer